Home|Best-Bschool-in-india-2018

DSIJ Mindshare

This travel tech start-up secures USD 3.9 million investment led by Easy Trip Planners Ltd This travel tech start-up secures USD 3.9 million investment led by Easy Trip Planners Ltd

This travel tech start-up secures USD 3.9 million investment led by Easy Trip Planners Ltd

The strategic investment will play a pivotal role in fueling the company's ambitious expansion plans while the company has experienced exceptional revenue growth, exceeding 100% from FY 2021-22 to 2022-23.

Prajwal Wakhare 0 629 Article rating: 3.2

EaseMyTrip CEO Nishant Pitti said the investment will help broaden nonhair travel services and improve offerings for corporate clients.

Read more
This small-cap real estate company gets a government NOD for a 12-acre commercial project; the penny stock is expected to perform well this quarter This small-cap real estate company gets a government NOD for a 12-acre commercial project; the penny stock is expected to perform well this quarter

This small-cap real estate company gets a government NOD for a 12-acre commercial project; the penny stock is expected to perform well this quarter

Foreign institutional holding has increased from 2.36 per cent to 3.54 per cent in the March 2024 quarter.

Prajwal Wakhare 0 1874 Article rating: 3.0

In the December 2023 Quarterly Results, the company reported a revenue of Rs 59.02 crore, up 4.48 per cent from the previous quarter's Rs 61.79 crore. Also, a 260.10 per cent increase compared to the Rs 16.39 crore reported a year ago. The company's net profit for the quarter stood at Rs 3.04 crore, a 15.15 per cent improvement from the Rs 2.64 crore in the previous quarter.

Read more
High ROE multibagger pharma stock: The board approved a bonus issue of 3:1 and declared dividend of Rs 4 per share, proposing to increase share capital to 1.25 crore! High ROE multibagger pharma stock: The board approved a bonus issue of 3:1 and declared dividend of Rs 4 per share, proposing to increase share capital to 1.25 crore!

High ROE multibagger pharma stock: The board approved a bonus issue of 3:1 and declared dividend of Rs 4 per share, proposing to increase share capital to 1.25 crore!

The stock gave multibagger returns of over 300 per cent in a year.

Prajwal Wakhare 0 808 Article rating: 3.4

The stock price jumped more than 9 per cent today due to the outcome of recently held a board meeting where they made some important financial decisions for the upcoming fiscal year 2023-24.

Read more
RSS
1345678910Last
DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

SEBI Registered Research Analyst Details:
Registered Name: DSIJ PRIVATE LIMITED
Type of registration: Non-Individual
Registration No.: INH000006396
Validity: Oct 05, 2018 - Perpetual

View Registration Certificate

SEBI Registered Investment Adviser Details:
Registered Name: DSIJ PRIVATE LIMITED
Type of registration: Non-Individual
Registration No.: INA000001142
Validity: Aug 19, 2019 - Perpetual

View Registration Certificate

Registered Address:
419-A, 4th floor, Arun Chambers,
Tardeo, Next to AC Market, Mumbai - 400 034.
Tel: +91 022-43476012/13/14/15 | Email: service@dsij.in
CIN No.: U22120MH2003PTC139276
GST No.: 27AACCR4303G1ZP
BASL Membership ID: 1346

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR

Disclaimer: "Registration granted by SEBI, membership of BASL and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors"

Investment in securities market is subject to market risks. Read all the related documents carefully before investing.

Any act of copying, reproducing, or distributing the content whether wholly or in part, for any purpose without the permission of DSIJ is strictly prohibited and shall be deemed to be copyright infringement.

Disclosures | Terms & Condition | Privacy Statement | WhiteList